⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for deleterious brca2 gene mutation

Every month we try and update this database with for deleterious brca2 gene mutation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube CancerNCT03586661
Deleterious BRC...
Deleterious BRC...
Endometrial Ade...
High Grade Ovar...
Platinum-Resist...
Primary Periton...
Progressive Dis...
Recurrent Endom...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Copanlisib
Niraparib
18 Years - M.D. Anderson Cancer Center
Surgery in Preventing Ovarian Cancer in Patients With Genetic MutationsNCT02760849
Deleterious BAR...
Deleterious BRC...
Deleterious BRC...
Deleterious BRI...
Deleterious EPC...
Deleterious MLH...
Deleterious MSH...
Deleterious MSH...
Deleterious PAL...
Deleterious PMS...
Deleterious RAD...
Deleterious RAD...
Hereditary Brea...
Premenopausal
Laboratory Biom...
Oophorectomy
Quality-of-Life...
Salpingectomy
Salpingo-Oophor...
30 Years - 50 YearsM.D. Anderson Cancer Center
Surgery in Preventing Ovarian Cancer in Patients With Genetic MutationsNCT02760849
Deleterious BAR...
Deleterious BRC...
Deleterious BRC...
Deleterious BRI...
Deleterious EPC...
Deleterious MLH...
Deleterious MSH...
Deleterious MSH...
Deleterious PAL...
Deleterious PMS...
Deleterious RAD...
Deleterious RAD...
Hereditary Brea...
Premenopausal
Laboratory Biom...
Oophorectomy
Quality-of-Life...
Salpingectomy
Salpingo-Oophor...
30 Years - 50 YearsM.D. Anderson Cancer Center
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic CancerNCT03432676
ATM Gene Mutati...
Deleterious BRC...
Deleterious BRC...
Homologous Reco...
Pancreatic Duct...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Stage IV Pancre...
Epacadostat
Pembrolizumab
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: